Department of Drug Design and Pharmacology > Employees
Christinna Vangsgaard Jørgensen
2100 København Ø
PhD project: The role of the GPRC6A receptor in mediating osteocalcin reversal of glucocorticoid-induced dysmetabolism.
The aim of the study is to determine how, under conditions of glucocorticoid excess, the bone hormone osteocalcin activates, either directly or indirectly, the GPRC6A receptor. I will perform the study in Hans Bräuner-Osborne's group in Copenhagen and in professor Markus Siebel's group at the ANZAC Institute in Sydney, Australia.